Tumeurs de la plèvre : Questions médicales fréquentes
Nom anglais: Pleural Neoplasms
Descriptor UI:D010997
Tree Number:C08.785.640
Termes MeSH sélectionnés :
Pilot Projects
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs de la plèvre : Questions médicales les plus fréquentes",
"headline": "Tumeurs de la plèvre : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tumeurs de la plèvre : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-29",
"dateModified": "2025-02-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tumeurs de la plèvre"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs de l'appareil respiratoire",
"url": "https://questionsmedicales.fr/mesh/D012142",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs de l'appareil respiratoire",
"code": {
"@type": "MedicalCode",
"code": "D012142",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.785"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Mésothéliome malin",
"alternateName": "Mesothelioma, Malignant",
"url": "https://questionsmedicales.fr/mesh/D000086002",
"about": {
"@type": "MedicalCondition",
"name": "Mésothéliome malin",
"code": {
"@type": "MedicalCode",
"code": "D000086002",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.785.640.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Épanchement pleural malin",
"alternateName": "Pleural Effusion, Malignant",
"url": "https://questionsmedicales.fr/mesh/D016066",
"about": {
"@type": "MedicalCondition",
"name": "Épanchement pleural malin",
"code": {
"@type": "MedicalCode",
"code": "D016066",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.785.640.700"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs de la plèvre",
"alternateName": "Pleural Neoplasms",
"code": {
"@type": "MedicalCode",
"code": "D010997",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Najib M Rahman",
"url": "https://questionsmedicales.fr/author/Najib%20M%20Rahman",
"affiliation": {
"@type": "Organization",
"name": "Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK."
}
},
{
"@type": "Person",
"name": "Kevin G Blyth",
"url": "https://questionsmedicales.fr/author/Kevin%20G%20Blyth",
"affiliation": {
"@type": "Organization",
"name": "School of Cancer Sciences, University of Glasgow, Glasgow, UK; Queen Elizabeth University Hospital, Glasgow, UK; Cancer Research UK Scotland Centre, Glasgow, UK. Electronic address: kevin.blyth@glasgow.ac.uk."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Michele Mondoni",
"url": "https://questionsmedicales.fr/author/Michele%20Mondoni",
"affiliation": {
"@type": "Organization",
"name": "Respiratory Unit, ASST Santi Paolo e Carlo, Department of Health Sciences, Università degli Studi di Milano, 20122 Milan, Italy."
}
},
{
"@type": "Person",
"name": "Giampietro Marchetti",
"url": "https://questionsmedicales.fr/author/Giampietro%20Marchetti",
"affiliation": {
"@type": "Organization",
"name": "Pulmonology Unit, ASST Spedali Civili, 25123 Brescia, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "SARS-CoV-2 rapid antigen screening of asymptomatic employees: a pilot project.",
"datePublished": "2022-09-12",
"url": "https://questionsmedicales.fr/article/36097245",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.17269/s41997-022-00691-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Health Disparities Investigator Development through a Team-Science Pilot Projects Program.",
"datePublished": "2023-03-30",
"url": "https://questionsmedicales.fr/article/37047951",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20075336"
}
},
{
"@type": "ScholarlyArticle",
"name": "Global pen pal education intervention among student pharmacists: A pilot project.",
"datePublished": "2022-09-22",
"url": "https://questionsmedicales.fr/article/36153244",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cptl.2022.09.020"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Disposable Diaper Collection Project in Langa, Cape Town, South Africa: A Pilot Study.",
"datePublished": "2024-09-27",
"url": "https://questionsmedicales.fr/article/39457265",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph21101292"
}
},
{
"@type": "ScholarlyArticle",
"name": "Changing the Playing Field: A Prehospital Blood Product Pilot Project in Rural North Georgia.",
"datePublished": "2023-02-16",
"url": "https://questionsmedicales.fr/article/36798046",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/00031348231157833"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012140"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs de l'appareil respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012142"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs de la plèvre",
"item": "https://questionsmedicales.fr/mesh/D010997"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tumeurs de la plèvre - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tumeurs de la plèvre",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tumeurs de la plèvre",
"description": "Comment diagnostique-t-on une tumeur de la plèvre ?\nQuels tests sont utilisés pour le mésothéliome ?\nLes marqueurs tumoraux sont-ils utiles ?\nQuels symptômes indiquent une tumeur pleurale ?\nL'imagerie par résonance magnétique est-elle nécessaire ?",
"url": "https://questionsmedicales.fr/mesh/D010997?mesh_terms=Pilot+Projects&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tumeurs de la plèvre",
"description": "Quels sont les symptômes courants des tumeurs pleurales ?\nLa douleur thoracique est-elle fréquente ?\nPeut-on avoir des symptômes sans tumeur visible ?\nLes symptômes varient-ils selon le type de tumeur ?\nLes symptômes peuvent-ils s'aggraver rapidement ?",
"url": "https://questionsmedicales.fr/mesh/D010997?mesh_terms=Pilot+Projects&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tumeurs de la plèvre",
"description": "Peut-on prévenir les tumeurs de la plèvre ?\nQuels facteurs de risque sont associés ?\nLe tabagisme influence-t-il le risque ?\nY a-t-il des vaccins pour prévenir ces tumeurs ?\nComment réduire l'exposition à l'amiante ?",
"url": "https://questionsmedicales.fr/mesh/D010997?mesh_terms=Pilot+Projects&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tumeurs de la plèvre",
"description": "Quels traitements sont disponibles pour les tumeurs pleurales ?\nLa chirurgie est-elle toujours nécessaire ?\nLa chimiothérapie est-elle efficace contre le mésothéliome ?\nQuels sont les effets secondaires des traitements ?\nLa radiothérapie est-elle utilisée en palliatif ?",
"url": "https://questionsmedicales.fr/mesh/D010997?mesh_terms=Pilot+Projects&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tumeurs de la plèvre",
"description": "Quelles complications peuvent survenir ?\nLes tumeurs pleurales peuvent-elles se propager ?\nComment gérer la douleur liée aux tumeurs ?\nY a-t-il un risque d'infection ?\nLes complications affectent-elles le pronostic ?",
"url": "https://questionsmedicales.fr/mesh/D010997?mesh_terms=Pilot+Projects&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tumeurs de la plèvre",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque de tumeurs pleurales ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe sexe influence-t-il le risque ?\nLes conditions environnementales affectent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D010997?mesh_terms=Pilot+Projects&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une tumeur de la plèvre ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par imagerie (CT, IRM) et biopsie pour confirmer la nature de la tumeur."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le mésothéliome ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie, des analyses de sang et des biopsies sont utilisés pour le mésothéliome."
}
},
{
"@type": "Question",
"name": "Les marqueurs tumoraux sont-ils utiles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains marqueurs comme le CA-125 peuvent aider à diagnostiquer les tumeurs pleurales."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une tumeur pleurale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques, une toux persistante et des difficultés respiratoires peuvent indiquer une tumeur."
}
},
{
"@type": "Question",
"name": "L'imagerie par résonance magnétique est-elle nécessaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM peut être utilisée pour évaluer l'extension des tumeurs pleurales, mais n'est pas toujours nécessaire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des tumeurs pleurales ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur thoracique, toux, essoufflement et parfois fièvre."
}
},
{
"@type": "Question",
"name": "La douleur thoracique est-elle fréquente ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur thoracique est un symptôme courant des tumeurs de la plèvre."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans tumeur visible ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes peuvent apparaître même si la tumeur est petite ou difficile à détecter."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de tumeur ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon qu'il s'agit d'une tumeur bénigne ou maligne."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils s'aggraver rapidement ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains types de tumeurs pleurales peuvent provoquer une aggravation rapide des symptômes."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les tumeurs de la plèvre ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais éviter l'exposition à l'amiante peut réduire le risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition à l'amiante, le tabagisme et certaines conditions environnementales augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque de développer des tumeurs pleurales, surtout avec l'amiante."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins pour prévenir ces tumeurs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins spécifiques pour prévenir les tumeurs de la plèvre."
}
},
{
"@type": "Question",
"name": "Comment réduire l'exposition à l'amiante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les lieux de travail à risque et suivez les réglementations de sécurité pour réduire l'exposition."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les tumeurs pleurales ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie selon le type de tumeur."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle toujours nécessaire ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la chirurgie dépend de la taille et du type de la tumeur, ainsi que de l'état du patient."
}
},
{
"@type": "Question",
"name": "La chimiothérapie est-elle efficace contre le mésothéliome ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chimiothérapie est souvent utilisée pour traiter le mésothéliome, mais son efficacité varie."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure fatigue, nausées, et problèmes respiratoires selon le traitement."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle utilisée en palliatif ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie peut être utilisée pour soulager les symptômes dans les cas avancés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'accumulation de liquide pleural, la douleur chronique et la dyspnée."
}
},
{
"@type": "Question",
"name": "Les tumeurs pleurales peuvent-elles se propager ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tumeurs pleurales peuvent se propager à d'autres parties du corps, notamment les poumons."
}
},
{
"@type": "Question",
"name": "Comment gérer la douleur liée aux tumeurs ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion de la douleur peut inclure des analgésiques, des traitements palliatifs et des interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque d'infection ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent être à risque d'infections pulmonaires en raison de la maladie ou des traitements."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles le pronostic ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent aggraver le pronostic et influencer les options de traitement."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'exposition à l'amiante, le tabagisme et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de tumeurs pleurales ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout chez les personnes exposées à des substances cancérigènes."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies pulmonaires ou d'exposition à des agents cancérigènes augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes sont généralement plus à risque de développer des tumeurs pleurales que les femmes."
}
},
{
"@type": "Question",
"name": "Les conditions environnementales affectent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, vivre près d'industries polluantes ou d'anciens sites d'amiante augmente le risque."
}
}
]
}
]
}
Rapid antigen screening can be effective in identifying infectious individuals in occupational settings to reduce transmission and outbreaks. We report results from a pilot project at the Greater Toro...
An employee screening program was piloted between March 8 and May 28, 2021, to implement rapid antigen testing for asymptomatic employees. Recruitment targeted enrolment of 400 employees and yielded p...
A total of 5117 tests were performed on 717 individuals over 12 weeks; 5091 tests were negative (99.5%), and 22 individuals tested positive (3.1% positivity rate). One hundred twenty-four (17%) comple...
This pilot program identified 22 (3.1%) potentially infectious employees. Onsite testing was feasible and highly accepted by this group of employees who completed the survey. Education resulted in rea...
Profound health disparities are widespread among Native Hawaiians, other Pacific Islanders, and Filipinos in Hawai'i. Efforts to reduce and eliminate health disparities are limited by a shortage of in...
Global health, a practice that prioritizes improving health and achieving health equity for all people worldwide, is a priority for pharmacists, schools, and pharmacy colleges. Several initiatives aim...
This mixed-method study included assigned engagement within a required or elective didactic course, followed by a post-experience survey. Each student was pre-assigned a pen pal from a cohort of pharm...
In total, 184 students completed the learning experience, and across both sites, 63 students completed the post-experience survey. The students' impressions of the PPP varied by site, yet most partici...
In developing countries, there is currently no established waste management plan that includes resource recovery from used disposable diapers (DDs) apart from incineration and landfilling. In low-inco...
In Georgia, the paramedic's scope of practice prohibited the initiation of blood products. Due to the rural landscape in Georgia, one region's Regional Trauma Advisory Committee (RTAC) advocated expan...
Approval was obtained from the state medical directors and the Office of EMS and Trauma. The project team addressed product selection, equipment, prehospital service selection, education, policies and...
The pilot project began in spring of 2020, and as of January 2023, there have been 100 field initiations and no adverse effects, demonstrating the safety of paramedics to initiate blood products in th...
Future physicians are insufficiently prepared for the topic of transgender identity during their studies. Relevant courses during undergraduate medical education are heterogeneous and not widely estab...
During summer semester 2021 (SS21), the knowledge level on transgender identity of 134 medical students in their fifth clinical semester was evaluated (phase 1). In addition, knowledge gain on gender ...
The students in SS21 did not feel sufficiently educated in the topic of transgender identity through their studies, but rated the relevance of the topic for their later profession as high. Learning ga...
One 90-minutes seminar led to a significant learning gain regarding the topic of transgender identity. Community-supported teaching is a promising way to impart knowledge in a qualified manner: Medica...
To trial methods for a future longitudinal study to: a) assess how the redevelopment of a large social housing estate affects the health of tenants; and b) act on health needs identified throughout th...
Participants recruited from the tenant population completed (online or face-to-face) a health questionnaire covering self-reported health status and behaviours, housing conditions, sense of community,...
A total of 24 tenants were recruited for the pilot study against a target sample size of 50. The health questionnaire and referral process worked as expected, with no issues reported....
This pilot study successfully trialled methods for: a) assessing tenants' health; and b) referring those identified as being likely to have unmet health service needs to a community-based link worker,...
We developed a paediatric haemodialysis trigger tool (pHTT) for application per haemodialysis (HD) session in children receiving intermittent in-centre HD and systematically monitored adverse events....
Single-centre quality improvement study performed over two 8-week cycles. Data collected prospectively using a 'per-dialysis session' pHTT tool including 54 triggers across six domains, adapted from a...
There were 241 triggers over 182 dialysis sessions, with 139 triggers in 91 HD sessions for 15 children, age range 28-205 months, over an 8-week period (first cycle) and 102 triggers in 91 HD sessions...
This pilot study demonstrates potential benefits of a bedside tool to monitor adverse events during haemodialysis in children. Thus, following interventions informed by the pHTT, the harm rate per ses...
American Indian Alaska Native (AIAN) youth have disproportionately higher rates of commercial tobacco product use compared to other racial and ethnic groups in the U.S. These rates underscore a need f...
The "Virtual Semester for Medical Research Aachen" (vSEMERA) is an international, interdisciplinary, virtual education program developed for health profession students. The first edition (2021) was ho...
vSEMERA was built on a virtual learning platform, the "vSEMERA-Campus", designed to foster students' learning process and social interactions. Maximum flexibility was offered through synchronous and a...
The program received a rating of 4.38 out of 5 stars. While it met most expectations (4.29 out of 5), participants were unable to attend as many courses as intended (2.81 out of 5), mainly due to sche...
vSEMERA represents a promising example of an online international learning and exchange program using pedagogical and technological elements of virtual collaboration and teaching. In addition to advan...